Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
How Salt Triggers Edema: Exploring Kidney Sodium Balance & Fluid Retention
Jul, 14 2025
Inactive Ingredients in Generic Medications: What You Need to Know
Nov, 29 2025
Remote Microphone Systems: How They Improve Speech in Noise for Hearing Loss
Feb, 23 2026
Chest Pain Evaluation: When to Go to the Emergency Department
Jan, 13 2026
Managing Growth and Appetite for Teens on ADHD Medication
Apr, 9 2026